Medical Device Network via Yahoo
Genetesis enrols first subject for MICRO2 trial
Center, The Christ Hospital, Saint Luke’s Health System Kansas City, and the University of Florida. Genetesis' CardioFlux MCG technology is at the forefront of this study. The trial's successful ...
18 hours ago